SYMBICORT Side Effects

6907922-8 | Cardiac Disorder, Dyspnoea, Heart Rate Abnormal
on Jul 27, 2010 Female patient from UNITED STATES , 74 years of age, weighting 121.9 lb, was diagnosed with dyspnoea and was treated with Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac disorder, dyspnoea, heart rate abnormal. Symbicort dosage: 2 Puff, 320 Mcg Bid. During the same period patient was treated with COMBIVENT (3 Puffs) (View Combivent Review and Combivent Label ), WARFARIN (View Warfarin Review and Warfarin Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), PACERONE (View Pacerone Review and Pacerone Label ), SPIRIVA (View Spiriva Review and Spiriva Label ). Patient was hospitalized.

6907921-6 | Abdominal Pain Upper, Mouth Ulceration
Patient was taking Symbicort (View Usage). Patient had the following side effects: abdominal pain upper, mouth ulceration on Jul 27, 2010 from CHINA Additional patient health information: Male patient , 69 years of age, was diagnosed with asthma (What is asthma?) and. Symbicort dosage: 320/9 Ug. Patient was hospitalized.

6907873-9 | Cardiac Operation, Cerebrovascular Accident, Fatigue, Knee Arthroplasty, Myocardial Infarction, Pneumonia, Sleep Apnoea Syndrome
Adverse event was reported on Jul 27, 2010 by a Female patient taking Symbicort (View Usage) (Dosage: 160 Mcgs) was diagnosed with chronic obstructive pulmonary disease and. Location: UNITED STATES , weighting 229.9 lb, After Symbicort was administered, patient had the following side effects: cardiac operation, cerebrovascular accident, fatigue, knee arthroplasty, myocardial infarction, pneumonia (What is pneumonia?), sleep apnoea syndrome. During the same period patient was treated with KLOZIPAM (View Klozipam Review and Klozipam Label ), CENTRUM SILVER (View Centrum Silver Review and Centrum Silver Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), PAXIL (View Paxil Review and Paxil Label ), PROTONIX (View Protonix Review and Protonix Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ). Patient was hospitalized.

6907698-4 | Asthma, Bronchopneumonia
on Aug 02, 2010 Male patient from JAPAN , 72 years of age, weighting 143.3 lb, was diagnosed with asthma (What is asthma?) and was treated with Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), bronchopneumonia. Symbicort dosage: 160/4.5 ?g One Inhalation. During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ). Patient was hospitalized.


6905845-1 | Ageusia, Anosmia
on Aug 02, 2010 Female patient from UNITED STATES , 75 years of age, weighting 112.0 lb, was diagnosed with chronic obstructive pulmonary disease, emphysema and was treated with Symbicort (View Usage). Patient had the following side effects: ageusia, anosmia. Symbicort dosage: 1 Puff Am And 1 Puff Pm Daily. During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), CALCIUM (View Calcium Review and Calcium Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ).

6905374-5 | Pyrexia
Patient was taking Symbicort (View Usage). After Symbicort was administered, patient had the following side effects: pyrexia on Jul 29, 2010 from UNITED STATES Additional patient health information: Female patient , 73 years of age, was diagnosed with asthma (What is asthma?), pneumonia (What is pneumonia?), cough and. Symbicort dosage: 80/4.5 Two Puffs. During the same period patient was treated with POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), MOXIFLOXACIN (View Moxifloxacin Review and Moxifloxacin Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), PROAIR HFA (As Needed) (View Proair Hfa Review and Proair Hfa Label ). Patient was hospitalized.

6899880-X | Hepatic Enzyme Increased
Adverse event was reported on Jul 27, 2010 by a Male patient taking Symbicort (View Usage) (Dosage: 2 Inhalations/bid) was diagnosed with chronic obstructive pulmonary disease, hypertension, insomnia and. Location: COLOMBIA , 82 years of age, Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased. During the same period patient was treated with LOSARTAN POSTASSIUM (View Losartan Postassium Review and Losartan Postassium Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

6887160-8 | Dyspnoea, Heart Rate Abnormal
on Jul 23, 2010 Female patient from UNITED STATES , 74 years of age, weighting 123.0 lb, was diagnosed with dyspnoea and was treated with Symbicort (View Usage). Patient had the following side effects: dyspnoea, heart rate abnormal. Symbicort dosage: 2 Puff, 320 Mcg Bid. During the same period patient was treated with COMBIVENT (3 Puffs) (View Combivent Review and Combivent Label ). Patient was hospitalized.

6882368-X | Anaemia, Dyspnoea, Vertigo
on Jul 20, 2010 Female patient from UNITED STATES , weighting 175.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Symbicort (View Usage). After Symbicort was administered, patient had the following side effects: anaemia, dyspnoea, vertigo. Symbicort dosage: 160 Mcg, 2 Puffs Two Times A Day. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6879911-3 | Coma
Patient was taking Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: coma on Jul 20, 2010 from UNITED STATES Additional patient health information: Male patient , 71 years of age, weighting 145.1 lb, was diagnosed with dyspnoea and. Symbicort dosage: Bid. Patient was hospitalized.

6876998-9 | Chronic Obstructive Pulmonary Disease, Incorrect Dose Administered
Adverse event was reported on Jul 15, 2010 by a Male patient taking Symbicort (View Usage) (Dosage: 160/4.5 Ug 2 Puffs) was diagnosed with chronic obstructive pulmonary disease and. Location: UNITED STATES , weighting 210.1 lb, Patient had the following side effects: chronic obstructive pulmonary disease, incorrect dose administered. During the same period patient was treated with ALBUTEROL SULATE (View Albuterol Sulate Review and Albuterol Sulate Label ). Patient was hospitalized.

6875892-7 | Ankle Fracture, Osteonecrosis
on Jul 16, 2010 Female patient from UNITED STATES , 61 years of age, weighting 149.7 lb, was diagnosed with asthma (What is asthma?), bone density decreased, pain (What is pain?), osteoarthritis (What is osteoarthritis?), pain management and was treated with Symbicort (View Usage). After Symbicort was administered, patient had the following side effects: ankle fracture, osteonecrosis (What is osteonecrosis?). Symbicort dosage: 320 Ug Daily. During the same period patient was treated with FOSAVANCE 2800 (View Fosavance 2800 Review and Fosavance 2800 Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ). Patient was hospitalized and became disabled.

6875653-9 | Bronchopneumonia
on Jul 20, 2010 Male patient from JAPAN , 72 years of age, weighting 143.3 lb, was diagnosed with asthma (What is asthma?) and was treated with Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: bronchopneumonia. Symbicort dosage: 160/4.5 ?g One Inhalation. During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ). Patient was hospitalized.

6875642-4 | Pain, Surgery, Tendon Rupture
Patient was taking Symbicort (View Usage). Patient had the following side effects: pain (What is pain?), surgery (What is surgery?), tendon rupture on Jul 19, 2010 from CANADA Additional patient health information: Male patient , 39 years of age, weighting 188.1 lb, . Symbicort dosage: 1 Dosage Form.

6870907-4 | Myocardial Infarction
Adverse event was reported on Jul 19, 2010 by a Male patient taking Symbicort (View Usage) (Dosage: ) . Location: CANADA , 42 years of age, After Symbicort was administered, patient had the following side effects: myocardial infarction. During the same period patient was treated with CLOZARIL (View Clozaril Review and Clozaril Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), CRESTOR (View Crestor Review and Crestor Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), COGENTIN (View Cogentin Review and Cogentin Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), ZANTAC (View Zantac Review and Zantac Label ).

6870905-0 |
on Jul 19, 2010 Male patient from CANADA , weighting 198.4 lb, was treated with Symbicort (View Usage). . Symbicort dosage: . During the same period patient was treated with XOLAIR (View Xolair Review and Xolair Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), COVERSYL (View Coversyl Review and Coversyl Label ), EZETROL (View Ezetrol Review and Ezetrol Label ), INSULIN (View Insulin Review and Insulin Label ), HUMULIN N (View Humulin N Review and Humulin N Label ).

6866477-7 | Aphonia
on Jul 13, 2010 Male patient from UNITED STATES , 53 years of age, was diagnosed with asthma (What is asthma?) and was treated with Symbicort (View Usage). Patient had the following side effects: aphonia. Symbicort dosage: . During the same period patient was treated with ADVAIR DISKUS 100/50 (500/50 Mcg Two Times A Day) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ADVAIR HFA CFC FREE INHALER (230/21 Mcg) (View Advair Hfa-cfc Free Inhaler Review and Advair Hfa-cfc Free Inhaler Label ), ZAFIRLUKAST (View Zafirlukast Review and Zafirlukast Label ), FEXOFENADINE HYDROCHLORID (View Fexofenadine Hydrochlorid Review and Fexofenadine Hydrochlorid Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SALBUTAMOL SULFATE (View Salbutamol Sulfate Review and Salbutamol Sulfate Label ).

6862232-2 | Atelectasis, Atrioventricular Block First Degree, Coronary Artery Disease, Electrocardiogram Qrs Complex Abnormal, International Normalised Ratio Decreased, Pneumonectomy
Patient was taking Symbicort (View Usage). After Symbicort was administered, patient had the following side effects: atelectasis, atrioventricular block first degree, coronary artery disease (What is coronary artery disease?), electrocardiogram qrs complex abnormal, international normalised ratio decreased, pneumonectomy on Jul 13, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 254.0 lb, was diagnosed with chronic obstructive pulmonary disease and. Symbicort dosage: 320 Mcg. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), FISHOILS (View Fishoils Review and Fishoils Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), GLUCOSAMINE/CHONDROITIN (View Glucosamine/chondroitin Review and Glucosamine/chondroitin Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ). Patient was hospitalized.

6862214-0 | Blood Pressure Inadequately Controlled, Constipation, Coronary Artery Occlusion, Cough, Labyrinthitis
Adverse event was reported on Jul 12, 2010 by a Female patient taking Symbicort (View Usage) (Dosage: 160/4.5 Mcgs) was diagnosed with asthma (What is asthma?), hypertension, hypothyroidism, anxiety (What is anxiety?) and. Location: BRAZIL , 46 years of age, weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: blood pressure inadequately controlled, constipation (What is constipation?), coronary artery occlusion, cough, labyrinthitis. During the same period patient was treated with ATACAND (View Atacand Review and Atacand Label ), SYNTHROID (Od) (View Synthroid Review and Synthroid Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), PLAVIX (Od) (View Plavix Review and Plavix Label ), PAROXETINE HCL (Od) (View Paroxetine Hcl Review and Paroxetine Hcl Label ), LEXOTAN (Od) (View Lexotan Review and Lexotan Label ). Patient was hospitalized.

6862073-6 | Gallbladder Disorder, Hepatic Enzyme Abnormal, Incorrect Dose Administered, Wheezing
on Jul 12, 2010 Male patient from BRAZIL , 51 years of age, weighting 220.5 lb, was diagnosed with asthma (What is asthma?), hypertension and was treated with Symbicort (View Usage). Patient had the following side effects: gallbladder disorder, hepatic enzyme abnormal, incorrect dose administered, wheezing. Symbicort dosage: 320/9 Mcgs. During the same period patient was treated with ATACAND HCT (8/12.5 Mgs) (View Atacand Hct Review and Atacand Hct Label ), LOSARTAN POSTASSIUM (View Losartan Postassium Review and Losartan Postassium Label ). Patient was hospitalized.

6855849-2 | Cardiovascular Disorder
on Jul 15, 2010 Female patient from RUSSIAN FEDERATION , 16 years of age, was treated with Symbicort (View Usage). After Symbicort was administered, patient had the following side effects: cardiovascular disorder. Symbicort dosage: .

6848254-6 | Coronary Arterial Stent Insertion
Patient was taking Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: coronary arterial stent insertion on Jul 07, 2010 from UNITED STATES Additional patient health information: Male patient , 73 years of age, weighting 254.0 lb, was diagnosed with chronic obstructive pulmonary disease and. Symbicort dosage: 320 Mcg.

6843441-5 | Hypokalaemia
Adverse event was reported on Jul 09, 2010 by a Male patient taking Symbicort (View Usage) (Dosage: 60, 4 Df Bid) was diagnosed with asthma (What is asthma?), cardiac failure, arrhythmia (What is arrhythmia?), angina pectoris, dyslipidaemia, thrombosis prophylaxis, enterocolitis and. Location: JAPAN , 66 years of age, weighting 143.3 lb, Patient had the following side effects: hypokalaemia. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), MEXITIL (View Mexitil Review and Mexitil Label ), NIKORANMART (View Nikoranmart Review and Nikoranmart Label ), LIVALO (View Livalo Review and Livalo Label ), BLOPRESS (View Blopress Review and Blopress Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), WARFARIN (View Warfarin Review and Warfarin Label ), MIYA BM (View Miya Bm Review and Miya Bm Label ).

6839374-0 | Pneumonia
on Jul 05, 2010 Female patient from BRAZIL , 34 years of age, was diagnosed with asthma (What is asthma?) and was treated with Symbicort (View Usage). After Symbicort was administered, patient had the following side effects: pneumonia (What is pneumonia?). Symbicort dosage: 320/9 Mcg. Patient was hospitalized.

6835400-3 | Osteoporotic Fracture
on Jul 05, 2010 Female patient from GERMANY , 84 years of age, weighting 125.7 lb, was diagnosed with chronic obstructive pulmonary disease, hypertension, prophylaxis against gastrointestinal ulcer, hypothyroidism, sleep disorder (What is sleep disorder?), multiple allergies, cardiac failure and was treated with Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: osteoporotic fracture. Symbicort dosage: 1 Df Bid. During the same period patient was treated with XIPAMIDE (View Xipamide Review and Xipamide Label ), PREDNISOLON (View Prednisolon Review and Prednisolon Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), L THYROXIN ^HENNING BERLIN^ (View L-thyroxin ^henning Berlin^ Review and L-thyroxin ^henning Berlin^ Label ), RADEDORM (View Radedorm Review and Radedorm Label ), XUSAL (View Xusal Review and Xusal Label ), DIGITOXIN TAB (5 Days A Week) (View Digitoxin Tab Review and Digitoxin Tab Label ), SPIRIVA (View Spiriva Review and Spiriva Label ). Patient was hospitalized.

6832714-8 | Compression Fracture, Fall
Patient was taking Symbicort (View Usage). Patient had the following side effects: compression fracture, fall (What is fall?) on Jul 02, 2010 from UNITED STATES Additional patient health information: Female patient , 90 years of age, weighting 117.9 lb, . Symbicort dosage: 320 Mcgs Two Puffs. Patient was hospitalized.

6831711-6 | Anxiety, Dry Mouth, Oral Discomfort, Pharyngeal Erythema, Stomatitis
Adverse event was reported on Jul 01, 2010 by a Male patient taking Symbicort (View Usage) (Dosage: 740 Mcg, Two Times A Day.) was diagnosed with chronic obstructive pulmonary disease, hypertonic bladder and. Location: UNITED STATES , 59 years of age, weighting 160.1 lb, After Symbicort was administered, patient had the following side effects: anxiety (What is anxiety?), dry mouth, oral discomfort, pharyngeal erythema, stomatitis. During the same period patient was treated with PROAIR HFA (As Required.) (View Proair Hfa Review and Proair Hfa Label ), TOVIAZ (View Toviaz Review and Toviaz Label ), LITHIUM (View Lithium Review and Lithium Label ), KLONOPIN (View Klonopin Review and Klonopin Label ). Patient was hospitalized.

6831699-8 | Anaphylactoid Reaction, Rash
on Jul 06, 2010 Female patient from JAPAN , weighting 88.18 lb, was diagnosed with asthma (What is asthma?) and was treated with Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactoid reaction, rash (What is rash?). Symbicort dosage: . During the same period patient was treated with EPHEDRA TEAS (View Ephedra Teas Review and Ephedra Teas Label ), ASUTOPUTIN (View Asutoputin Review and Asutoputin Label ), CRAVIT (View Cravit Review and Cravit Label ), SISAAL (View Sisaal Review and Sisaal Label ), MUCOTRON (View Mucotron Review and Mucotron Label ).

6826350-7 | Blood Pressure Increased, Loss Of Consciousness, Palpitations
on Jun 30, 2010 Female patient from UNITED STATES , 41 years of age, was diagnosed with asthma (What is asthma?) and was treated with Symbicort (View Usage). Patient had the following side effects: blood pressure increased, loss of consciousness, palpitations. Symbicort dosage: 320 Mcg Two Puffs.

6826174-0 | Aphonia, Cough, Dry Throat, Nasopharyngitis, Oropharyngeal Pain, Pneumonia, Pyrexia
Patient was taking Symbicort (View Usage). After Symbicort was administered, patient had the following side effects: aphonia, cough, dry throat, nasopharyngitis, oropharyngeal pain, pneumonia (What is pneumonia?), pyrexia on Jun 30, 2010 from BRAZIL Additional patient health information: Male patient , 70 years of age, weighting 180.8 lb, was diagnosed with asthma (What is asthma?), chronic obstructive pulmonary disease, diabetes mellitus, hypercholesterolaemia, anxiety (What is anxiety?), prostatic specific antigen and. Symbicort dosage: 160/4.5 Ug. During the same period patient was treated with VANNAIR (View Vannair Review and Vannair Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), SINVASTATINA (View Sinvastatina Review and Sinvastatina Label ), FLUOXETINA (View Fluoxetina Review and Fluoxetina Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), CIPRO (View Cipro Review and Cipro Label ), EURTHYROX (View Eurthyrox Review and Eurthyrox Label ).

6826055-2 | Benign Neoplasm Of Prostate, Cough, Dyspnoea
Adverse event was reported on Jun 30, 2010 by a Male patient taking Symbicort (View Usage) (Dosage: 160/4.5 Mcg) was diagnosed with asthma (What is asthma?), prostatic disorder and. Location: BRAZIL , 62 years of age, weighting 123.5 lb, Patient experienced the following unwanted or unexpected effects: benign neoplasm of prostate, cough, dyspnoea. Patient was hospitalized.

6822118-6 | Dyspnoea
on Jun 29, 2010 Female patient from BRAZIL , 14 years of age, weighting 154.3 lb, was diagnosed with asthma (What is asthma?) and was treated with Symbicort (View Usage). Patient had the following side effects: dyspnoea. Symbicort dosage: 320/9 Mcg.

6820005-0 | Ankle Fracture, Osteonecrosis
on Jun 28, 2010 Female patient from UNITED STATES , 61 years of age, weighting 149.7 lb, was diagnosed with asthma (What is asthma?), bone density decreased, pain (What is pain?), osteoarthritis (What is osteoarthritis?), pain management and was treated with Symbicort (View Usage). After Symbicort was administered, patient had the following side effects: ankle fracture, osteonecrosis (What is osteonecrosis?). Symbicort dosage: 320 Ug Daily. During the same period patient was treated with FOSAVANCE 2800 (View Fosavance 2800 Review and Fosavance 2800 Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ). Patient was hospitalized and became disabled.

6819988-4 | Oedema
Patient was taking Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: oedema on Jun 28, 2010 from JAPAN Additional patient health information: Female patient , 30 years of age, was diagnosed with asthma (What is asthma?) and. Symbicort dosage: 2 Df, Two Times A Day..

6819541-2 | Asbestosis, Chronic Obstructive Pulmonary Disease
Adverse event was reported on Jun 28, 2010 by a Male patient taking Symbicort (View Usage) (Dosage: 320 Ug Bid) was diagnosed with chronic obstructive pulmonary disease, asbestosis and. Location: UNITED STATES , 78 years of age, weighting 205.0 lb, Patient had the following side effects: asbestosis, chronic obstructive pulmonary disease. During the same period patient was treated with SPIRIVA (View Spiriva Review and Spiriva Label ), FLUTICASONE (View Fluticasone Review and Fluticasone Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LOSARTAN POSTASSIUM (View Losartan Postassium Review and Losartan Postassium Label ), FEXOFENADINE (View Fexofenadine Review and Fexofenadine Label ), ROSUVASTATIN (View Rosuvastatin Review and Rosuvastatin Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

6819449-2 | Dyspnoea, Feeling Cold, Palpitations, Rash
on Jun 29, 2010 Female patient from JAPAN , 34 years of age, weighting 88.18 lb, was diagnosed with cough and was treated with Symbicort (View Usage). After Symbicort was administered, patient had the following side effects: dyspnoea, feeling cold, palpitations, rash (What is rash?). Symbicort dosage: . During the same period patient was treated with EPHEDRA TEAS (View Ephedra Teas Review and Ephedra Teas Label ), ASUTOPUTIN (View Asutoputin Review and Asutoputin Label ), CRAVIT (View Cravit Review and Cravit Label ), SISAAL (View Sisaal Review and Sisaal Label ), MUCOTRON (View Mucotron Review and Mucotron Label ).

6818129-7 | Fall, Thrombosis
on Jun 24, 2010 Female patient from UNITED STATES , 59 years of age, was treated with Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), thrombosis. Symbicort dosage: .

6816881-8 | Hypoaesthesia, Muscle Spasms, Tremor
Patient was taking Symbicort (View Usage). Patient had the following side effects: hypoaesthesia, muscle spasms, tremor on Jun 28, 2010 from JAPAN Additional patient health information: Female patient , 30 years of age, was diagnosed with asthma (What is asthma?) and. Symbicort dosage: 1 Df, Four Times A Day.. During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ), THEOLONG (View Theolong Review and Theolong Label ).

6814000-5 | Hepatic Enzyme Increased
Adverse event was reported on Jun 25, 2010 by a Male patient taking Symbicort (View Usage) (Dosage: 2 Inhalations/bid) was diagnosed with chronic obstructive pulmonary disease, hypertension, insomnia and. Location: COLOMBIA , 82 years of age, After Symbicort was administered, patient had the following side effects: hepatic enzyme increased. During the same period patient was treated with LOSARTAN POSTASSIUM (View Losartan Postassium Review and Losartan Postassium Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

6812322-5 | Dyspnoea
on Jun 28, 2010 Male patient from UNITED STATES , 43 years of age, weighting 190.0 lb, was diagnosed with asthma (What is asthma?), rhinitis allergic and was treated with Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea. Symbicort dosage: 160/4.5, Two Puffs. During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

6812246-3 | Abnormal Behaviour, Agitation, Anxiety
on Jun 23, 2010 Female patient from ITALY , 60 years of age, was diagnosed with asthma (What is asthma?) and was treated with Symbicort (View Usage). Patient had the following side effects: abnormal behaviour, agitation, anxiety (What is anxiety?). Symbicort dosage: 160+ 4.5 Ug. During the same period patient was treated with PERINDOPRIL (View Perindopril Review and Perindopril Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), AERIUS (View Aerius Review and Aerius Label ), METFONORM (View Metfonorm Review and Metfonorm Label ).

6812245-1 | Condition Aggravated
Patient was taking Symbicort (View Usage). After Symbicort was administered, patient had the following side effects: condition aggravated on Jun 23, 2010 from CANADA Additional patient health information: Female patient , 57 years of age, . Symbicort dosage: .

6812229-3 | Atrial Septal Defect, Electrocardiogram Abnormal, Joint Dislocation
Adverse event was reported on Jun 22, 2010 by a Female patient taking Symbicort (View Usage) (Dosage: 160/4.5 Mcg Daily) was diagnosed with asthma (What is asthma?) and. Location: BRAZIL , 55 years of age, weighting 152.1 lb, Patient experienced the following unwanted or unexpected effects: atrial septal defect, electrocardiogram abnormal, joint dislocation. During the same period patient was treated with ALENIA (View Alenia Review and Alenia Label ), SERETIDE (View Seretide Review and Seretide Label ).

6812191-3 | Hypoaesthesia, Muscle Spasms, Tremor
on Jun 23, 2010 Female patient from JAPAN , 30 years of age, was diagnosed with asthma (What is asthma?) and was treated with Symbicort (View Usage). Patient had the following side effects: hypoaesthesia, muscle spasms, tremor. Symbicort dosage: . During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ), THEOLONG (View Theolong Review and Theolong Label ).

6809831-1 | Aneurysm, Chronic Obstructive Pulmonary Disease
on Jun 21, 2010 Female patient from UNITED STATES , 67 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Symbicort (View Usage). After Symbicort was administered, patient had the following side effects: aneurysm (What is aneurysm?), chronic obstructive pulmonary disease. Symbicort dosage: 160/4.5 Mcg Two Puffs Two Times A Day. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ). Patient was hospitalized.

6802703-8 | Aphonia, Cough, Pneumonia, Pyrexia, Wheezing
Patient was taking Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: aphonia, cough, pneumonia (What is pneumonia?), pyrexia, wheezing on Jun 17, 2010 from BRAZIL Additional patient health information: Male patient , 70 years of age, weighting 174.2 lb, was diagnosed with asthma (What is asthma?), chronic obstructive pulmonary disease, diabetes mellitus, hypercholesterolaemia, anxiety (What is anxiety?), prostatic specific antigen and. Symbicort dosage: 160/4.5 Ug. During the same period patient was treated with METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), SINVASTATINA (View Sinvastatina Review and Sinvastatina Label ), FLUOXETINA (View Fluoxetina Review and Fluoxetina Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), CIPRO (View Cipro Review and Cipro Label ), EURTHYROX (View Eurthyrox Review and Eurthyrox Label ), CITALOPRAN (View Citalopran Review and Citalopran Label ).

6800780-1 | Bronchopneumonia
Adverse event was reported on Jun 23, 2010 by a Male patient taking Symbicort (View Usage) (Dosage: 160 Mcg Bid) was diagnosed with chronic obstructive pulmonary disease and. Location: UNITED STATES , 57 years of age, weighting 192.0 lb, Patient had the following side effects: bronchopneumonia. During the same period patient was treated with VENTOLIN (View Ventolin Review and Ventolin Label ), SPIRIVA (View Spiriva Review and Spiriva Label ). Patient was hospitalized.

6795248-5 | Tremor
on Jun 17, 2010 Female patient from JAPAN , weighting 136.7 lb, was diagnosed with asthma (What is asthma?) and was treated with Symbicort (View Usage). After Symbicort was administered, patient had the following side effects: tremor. Symbicort dosage: 4 Df, Two Times A Day.. During the same period patient was treated with DECACORT (View Decacort Review and Decacort Label ), PREDONINE (View Predonine Review and Predonine Label ), TULOBUTEROL (View Tulobuterol Review and Tulobuterol Label ), ADOAIR (View Adoair Review and Adoair Label ), THEO SLOW (View Theo-slow Review and Theo-slow Label ), KIPRES (View Kipres Review and Kipres Label ), AZELASTINE HCL (View Azelastine Hcl Review and Azelastine Hcl Label ).

6790195-7 | Device Malfunction, Hip Fracture
on Jun 16, 2010 Female patient from UNITED STATES , weighting 179.9 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Symbicort (View Usage). Patient experienced the following unwanted or unexpected effects: device malfunction, hip fracture. Symbicort dosage: 80/4.5 Ug 2 Puffs Twice A Day. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), AVALIDE (View Avalide Review and Avalide Label ), CALCIUM WITH VITAMIN D (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6783573-3 | Condition Aggravated
Patient was taking Symbicort (View Usage). Patient had the following side effects: condition aggravated on Jun 15, 2010 from CANADA Additional patient health information: Female patient , 57 years of age, . Symbicort dosage: .